Night-time sedating H1-antihistamine increases daytime somnolence but not treatment efficacy in chronic spontaneous urticaria: A randomized controlled trial

British Journal of Dermatology

Volumn 171, Issue 1, 2014, Pages 148-154

  Staevska, M ^a   Gugutkova, M ^a   Lazarova, C ^a   Kralimarkova, T ^a   Dimitrov, V ^a   Zuberbier, T ^b   Church, M K ^b   Popov, T A ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BILASTINE; CETIRIZINE; CHLOROPYRAMINE; CINNARIZINE; DESLORATADINE; FEXOFENADINE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; LEVOCETIRIZINE;

ADULT; AGED; ARTICLE; CHRONIC SPONTANEOUS URTICARIA; CHRONIC URTICARIA; CLINICAL ARTICLE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DAYTIME SOMNOLENCE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EVENING DOSAGE; FEMALE; HUMAN; MALE; MONOTHERAPY; NIGHT SLEEP; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEDATION; SLEEP DISORDER; URTICARIA ACTIVITY SCORE; CHEMICALLY INDUCED; CHRONIC DISEASE; COMPARATIVE STUDY; CROSSOVER PROCEDURE; DRUG ADMINISTRATION; DRUG COMBINATION; MIDDLE AGED; PATIENT SELECTION; TREATMENT OUTCOME; URTICARIA; YOUNG ADULT;

ADULT; AGED; CETIRIZINE; CHRONIC DISEASE; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HISTAMINE H1 ANTAGONISTS; HISTAMINE H1 ANTAGONISTS, NON-SEDATING; HUMANS; HYDROXYZINE; MALE; MIDDLE AGED; PATIENT SELECTION; QUALITY OF LIFE; SLEEP WAKE DISORDERS; TREATMENT OUTCOME; URTICARIA; YOUNG ADULT;

EID: 84904917137     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12846     Document Type: Article

References (21)

1. 2LEN task force report. Allergy 2011; 66: 317-30.
2. O'Donnell BF, Lawlor F, Simpson J, et al,. The impact of chronic urticaria on the quality of life. Br J Dermatol 1997; 136: 197-201.
3. Baiardini I, Pasquali M, Braido F, et al,. A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL). Allergy 2005; 60: 1073-8.
4. Murota H, Kitaba S, Tani M, et al,. Effects of nonsedative antihistamines on productivity of patients with pruritic skin diseases. Allergy 2010; 65: 929-30.
5. 2LEN/EDF/WAO guideline: management of urticaria. Allergy 2009; 64: 1427-43.
6. Godse KV, Zawar V, Krupashankar D, et al,. Consensus statement on the management of urticaria. Indian J Dermatol 2011; 56: 485-9.
7. Chow SK,. Management of chronic urticaria in Asia: 2010 AADV consensus guidelines. Asia Pac Allergy 2012; 2: 149-60.
8. 2LEN position paper. Allergy 2010; 65: 459-66.
9. Druce HM, Thoden WR, Mure P, et al,. Brompheniramine, loratadine, and placebo in allergic rhinitis: a placebo-controlled comparative clinical trial. J Clin Pharmacol 1998; 38: 382-9.
10. 1-receptor antagonists). Ann Allergy Asthma Immunol 1995; 75: 507-14.
11. Joint Task Force on Practice Parameters. The diagnosis and management of urticaria: a practice parameter part I: acute urticaria/angioedema; part II: chronic urticaria/angioedema. Ann Allergy Asthma Immunol 2000; 85: 521-44.
12. Grattan CE, Humphreys F, British Association of Dermatologists Therapy Group and Audit Subcommittee. Guidelines for evaluation and management of urticaria in adults and children. Br J Dermatol 2007; 157: 1116-23.
13. Powell RJ, Du Toit GL, Siddique N, et al,. BSACI guidelines for the management of chronic urticaria and angio-oedema. Clin Exp Allergy 2007; 37: 631-50.
14. Staevska M, Popov TA, Kralimarkova T, et al,. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol 2010; 125: 676-82.
15. 2LEN/EDF/WAO guideline: definition, classification and diagnosis of urticaria. Allergy 2009; 64: 1417-26.
16. Kapp A, Demarteau N,. Cost effectiveness of levocetirizine in chronic idiopathic urticaria: a pooled analysis of two randomised controlled trials. Clin Drug Investig 2006; 26: 1-11.
17. Klimek L,. Levocetirizine: from scientific evidence to a potent modern-day treatment of today's allergic patients. Drugs Today (Barc) 2009; 45: 213-25.
18. 1-antihistamines and urticaria: how can we predict the best drug for our patient? Clin Exp Allergy 2012; 42: 1423-9.
19. Potenzieri C, Undem BJ,. Basic mechanisms of itch. Clin Exp Allergy 2012; 42: 8-19.
20. Simons FE, Simons KJ, Frith EM,. The pharmacokinetics and antihistaminic of the H1 receptor antagonist hydroxyzine. J Allergy Clin Immunol 1984; 73: 69-75.
21. Murota H, Kitaba S, Tani M, et al,. Impact of sedative and non-sedative antihistamines on the impaired productivity and quality of life in patients with pruritic skin diseases. Allergol Int 2010; 59: 345-54.